The HLA gene complex in thyroid autoimmunity: From epidemiology to etiology

Journal of Autoimmunity

Volumn 30, Issue 1-2, 2008, Pages 58-62

  Jacobson, Eric M ^a   Huber, Amanda ^a   Tomer, Yaron ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Association; Gene; Graves' disease; Hashimoto's thyroiditis; HLA; Linkage; Thyroid

Indexed keywords

AMINO ACID; ANTIGEN; ARGININE; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA DR3 ANTIGEN; IODINE; PEPTIDE; THYROGLOBULIN;

ALLELE; AMINO ACID SUBSTITUTION; AUTOIMMUNE THYROIDITIS; CAUCASIAN; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENT; EPIDEMIOLOGICAL DATA; ETHNICITY; FAMILY STUDY; GENE; GENE IDENTIFICATION; GENE INTERACTION; GRAVES DISEASE; HASHIMOTO DISEASE; HLA SYSTEM; INTERVENTION STUDY; KNOWLEDGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MODULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK; TWINS;

AUTOANTIBODIES; AUTOIMMUNITY; GENES, MHC CLASS I; GENES, MHC CLASS II; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HASHIMOTO DISEASE; HLA-DR ANTIGENS; HUMANS; POLYMORPHISM, GENETIC; THYROGLOBULIN; THYROID GLAND;

EID: 38049068750     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2007.11.010     Document Type: Review

References (58)

1. Prabhakar B.S., Bahn R.S., and Smith T.J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24 6 (2003) 802-835
2. Weetman A.P. Chronic autoimmune thyroiditis. In: Braverman L.E., and Utiger R.D. (Eds). Werner and Ingbar's the thyroid (2000), Lippincott Williams and Wilkins, Philadelphia 721-732
3. Jacobson E.M., and Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28 (2007) 85-98
4. Tomer Y., and Davies T.F. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev 24 (2003) 694-717
5. Nelson J.L., and Hansen J.A. Autoimmune disease and HLA. CRC Crit Rev Immunol 10 (1990) 307-328
6. Farid N.R., Stone E., and Johnson G. Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf) 13 (1980) 535-544
7. Farid N.R. Graves' disease. In: Farid N.R. (Ed). HLA in endocrine and metabolic disorders (1981), Academic Press 85-143
8. Heward J.M., Allahabadia A., Daykin J., Carr-Smith J., Daly A., Armitage M., et al. Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab 83 (1998) 3394-3397
9. Yanagawa T., Mangklabruks A., Chang Y.B., Okamoto Y., Fisfalen M.-E., Curran P.G., et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 76 (1993) 1569-1574
10. Marga M., Denisova A., Sochnev A., Pirags V., and Farid N.R. Two HLA DRB 1 alleles confer independent genetic susceptibility to Graves disease: relevance of cross-population studies. Am J Med Genet 102 2 (2001) 188-191
11. Zamani M., Spaepen M., Bex M., Bouillon R., and Cassiman J.J. Primary role of the HLA class II DRB1*0301 allele in Graves disease. Am J Med Genet 95 5 (2000) 432-437
12. Davies T.F., and Amino N. A new classification for human autoimmune thyroid disease. Thyroid 3 4 (1993) 331-333
13. Tandon N., Zhang L., and Weetman A.P. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol (Oxf) 34 (1991) 383-386
14. Petrone A., Giorgi G., Mesturino C.A., Capizzi M., Cascino I., Nistico L., et al. Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid 11 2 (2001) 171-175
15. Golden B., Levin L., Ban Y., Concepcion E., Greenberg D.A., and Tomer Y. Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90 8 (2005) 4904-4911
16. Kong Y.C., Lomo L.C., Motte R.W., Giraldo A.A., Baisch J., Strauss G., et al. HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene. J Exp Med 184 3 (1996) 1167-1172
17. Badenhoop K., Schwartz G., Walfish P.G., Drummond V., Usadel K.H., and Bottazzo G.F. Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J Clin Endocrinol Metab 71 (1990) 1131-1137
18. Inoue D., Sato K., Enomoto T., Sugawa H., Maeda M., Inoko H., et al. Correlation of HLA types and clinical findings in Japanese patients with hyperthyroid Graves' disease: evidence indicating the existence of four subpopulations. Clin Endocrinol (Oxf) 36 1 (1992) 75-82
19. Katsuren E., Awata T., Matsumoto C., and Yamamoto K. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocrinol Jpn 41 6 (1994) 599-603
20. Ohtsuka K., and Nakamura Y. Human leukocyte antigens associated with hyperthyroid Graves ophthalmology in Japanese patients. Am J Ophthalmol 126 6 (1998) 805-810
21. Cavan D.A., Penny M.A., Jacobs K.H., Kelly M.A., Jenkins D., Mijovic C., et al. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol (Oxf) 40 (1994) 63-66
22. Chan S.H., Lin Y.N., Wee G.B., Ren E.C., Lui K.F., and Cheah J.S. Human leucocyte antigen DNA typing in Singaporean Chinese patients with Graves' disease. Ann Acad Med Singap 22 4 (1993) 576-579
23. Chen Q.Y., Nadell D., Zhang X.Y., Kukreja A., Huang Y.J., Wise J., et al. The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans. J Clin Endocrinol Metab 85 4 (2000) 1545-1549
24. Maciel L.M., Rodrigues S.S., Dibbern R.S., Navarro P.A., and Donadi E.A. Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11 1 (2001) 31-35
25. Honda K., Tamai H., Morita T., Kuma K., Nishimura Y., and Sasazuki T. Hashimoto's thyroiditis and HLA in Japanese. J Clin Endocrinol Metab 69 (1989) 1268-1273
26. Hawkins B.R., Lam K.S.L., Ma J.T.C., Wang C., and Yeung R.T.T. Strong association between HLA-DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol 114 (1987) 543-546
27. Todd J.A., Bell J.I., and McDevitt H.O. HLA-DQbeta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329 (1987) 599-604
28. Ban Y., Davies T.F., Greenberg D.A., Concepcion E.S., Osman R., Oashi T., et al. Arginine at position 74 of the HLA-DRb1 chain is associated with Graves' disease. Genes Immun 5 (2004) 203-208
29. Simmonds M.J., Howson J.M., Heward J.M., Cordell H.J., Foxall H., Carr-Smith J., et al. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 76 1 (2005) 157-163
30. Buus S., Sette A., and Grey H.M. The interaction between protein-derived immunogenic peptides and Ia. Immunol Rev 98 (1987) 115-141
31. Faas S., and Trucco M. The genes influencing the susceptibility to IDDM in humans. J Endocrinol Invest 17 (1994) 477-495
32. Aitman T.J., and Todd J.A. Molecular genetics of diabetes mellitus. Baillière's Clin Endocrinol Metab 9 (1995) 631-656
33. Morel P.A., Dorman J.S., Todd J.A., McDevitt H.O., and Trucco M. Aspartic acid at position 57 of the HLA-DQ beta-chain protects against type I diabetes: a family study. Proc Natl Acad Sci U S A 85 (1988) 8111-8115
34. Wucherpfennig K.W. Insights into autoimmunity gained from structural analysis of MHC-peptide complexes. Curr Opin Immunol 13 6 (2001) 650-656
35. Sawai Y., and DeGroot L.J. Binding of human thyrotropin receptor peptides to a Graves' disease-predisposing human leukocyte antigen class II molecule. J Clin Endocrinol Metab 85 3 (2000) 1176-1179
36. Hodge S.E., Ban Y., Strug L.J., Greenberg D.A., Davies T.F., Concepcion E.S., et al. Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 16 4 (2006) 351-355
37. Bottazzo G.F., Pujol Borrell R., Hanafusa T., and Feldmann M. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2 (1983) 1115-1119
38. Hanafusa T., Pujol Borrell R., Chiovato L., Russell R.C., Doniach D., and Bottazzo G.F. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity. Lancet 2 (1983) 1111-1115
39. Jacobson E.M., Huber A.K., Akeno N., Sivak M., Li C.W., Concepcion E., et al. A CD40 Kozak sequence polymorphism and susceptibility to antibody-mediated autoimmune conditions: the role of CD40 tissue-specific expression. Genes Immun 8 (2007) 205-214
40. Abel K., Reneland R., Kammerer S., Mah S., Hoyal C., Cantor C.R., et al. Genome-wide SNP association: identification of susceptibility alleles for osteoarthritis. Autoimmun Rev 5 (2006) 258-263
41. Abraham M., Karni A., Dembinsky A., Miller A., Gandhi R., Anderson D., et al. In vitro induction of regulatory T cells by anti-CD3 antibody in humans. J Autoimmun 30 (2008) 21-28
42. Alper C.A., Husain Z., Larsen C.E., Dubey D.P., Stein R., Day C., et al. Incomplete penetrance of susceptibility genes for MHC-determined immunoglobulin deficiencies in monozygotic twins discordant for type 1 diabetes. J Autoimmun 27 2 (2006) 89-95
43. Anaya J.M., Castiblanco J., Tobón G.J., García J., Abad V., Cuervo H., et al. Familial clustering of autoimmune diseases in patients with type 1 diabetes mellitus. J Autoimmun 26 3 (2006) 208-214
44. Andreoli L., Pregnolato F., Burlingame R.W., Allegri F., Rizzini S., Fanelli V., et al. Antinucleosome antibodies in primary antiphospholipid syndrome: a hint at systemic autoimmunity. J Autoimmun 30 (2008) 51-57
45. Awdeh Z.L., Yunis E.J., Audeh M.J., Fici D., Pugliese A., Larsen C.E., et al. A genetic explanation for the rising incidence of type 1 diabetes, a polygenic disease. J Autoimmun 27 (2006) 174-181
46. Binard A., Le Pottier L., Saraux A., Devauchelle-Pensec V., Pers J.-O., and Youinou P. Does the BAFF dysregulation play a major role in the pathogenesis of systemic lupus erythematosus?. J Autoimmun 30 (2008) 63-67
47. Gleicher N., and Barad D.H. Gender as risk factor for autoimmune diseases. J Autoimmun 28 (2007) 1-6
48. Kallenberg C. Pathogenesis of PR3-ANCA associated vasculitis. J Autoimmun 30 (2008) 29-36
49. Mackay I.R., Leskovsek N.V., and Rose N.R. Cell damage and autoimmunity: a critical appraisal. J Autoimmun 30 (2008) 5-11
50. Nakanishi Y., Tsuneyama K., Fujimoto M., Salunga T.L., Nomoto K., An J.-L., et al. Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia. J Autoimmun 30 (2008) 42-50
51. Nowling T.K., and Gilkeson G.S. Regulation of Fli1 gene expression and lupus. Autoimmun Rev 5 (2006) 377-382
52. Poletaev A., Stepanyuk V., and Gershwin M. Integrating immunity: the immunculus and self reactivity. J Autoimmun 30 (2008) 68-73
53. Praprotnik S., Sodin-Semrl S., Tomsic M., and Shoenfeld Y. The curiously suspicious: infectious disease may ameliorate an ongoing autoimmune destruction in systemic lupus erythematosus patients. J Autoimmun 30 (2008) 37-41
54. Recalcati S., Invernizzi P., Arosio P., and Cairo G. New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity. J Autoimmun 30 (2008) 84-89
55. Reveille J.D. The genetic basis of autoantibody production. Autoimmun Rev 5 (2006) 389-398
56. Sanchez-Pernaute O., Ospelt C., Neidhart M., and Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun 30 (2008) 12-20
57. Shoenfeld Y., and Gershwin M. Autoimmunity: from the mosaic to the kaleidoscope. J Autoimmun 30 (2008) 1-4
58. Steiman-Shimony A., et al. Immunoglobulin variable-region gene mutational lineage tree analysis: application to autoimmune diseases. Autoimmun Rev 5 (2006) 242-251